Anzeige
Mehr »
Mittwoch, 11.02.2026 - Börsentäglich über 12.000 News
Breaking News: Pacifica meldet neue hochgradige Entdeckung und genau deshalb kann der Markt das nicht ignorieren
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
22 Leser
Artikel bewerten:
(0)

Electronic Data Capture Systems Market Worth $1.16 Billion by 2025: Grand View Research, Inc.

SAN FRANCISCO, April 10, 2017 /PRNewswire/ --

The global electronic data capture (EDC) systems market is expected to reach USD 1.16 billion by 2025, according to a new study by Grand View Research, Inc. The rising demand for software solutions in clinical trials, increasing R&D expenditure by companies in healthcare, supportive government initiatives to boost trials, and increasing number of potential customers implementing Electronic Data Capture (EDC) systems are some of the key factors contributing to the market growth.

(Logo: http://photos.prnewswire.com/prnh/20150105/723757 )

The market is growing rapidly owing to the technological advancements in eClinical solutions and this is anticipated to serve this industry with future growth opportunities. Furthermore, increasing awareness pertaining to EDC solutions is predicted to fuel the demand in near future. Moreover, government organizations such as Agency for Healthcare Research and Quality and The Office of National Coordinator for Health Information Technology are promoting the adoption of electronic systems for data management. The aforementioned factors have resulted in the rising adoption of electronic data collection by pharmaceutical companies.

Moreover, increasing adoption of EDC systems by major pharmaceuticals to propagate clinical trials is predicted to provide this market with lucrative growth. For instance, in May 2016, Simbec-Orion Group selected Oracle's product, the Siebel Clinical Trial Management System, to strengthen its development processes and to expand its international operations & business. The system will provide efficient data capture and speed up the trial timelines. The strategies like this are anticipated to boost demand in coming years.

Browse full research report with TOC on "Electronic Data Capture (EDC) Systems Market Analysis By Component, By Delivery Mode (Web Based, Licensed Enterprise, Cloud Based), By Development Phase (Phase I, II, III, IV), By End-use, And Segment Forecasts, 2014 - 2025" at: http://www.grandviewresearch.com/industry-analysis/electronic-data-capture-edc-systems-market

Further key findings from the report suggest:

  • The software segment is predicted to witness lucrative growth owing to growing adoption by large pharmaceutical companies
  • The cloud-based segment is anticipated to experience the fastest growth as it allows easy data access over remote locations and provides larger storage space
  • Phase I clinical trials segment is expected to exhibit fastest CAGR over the forecast period as consequence of the rising R&D expenditure on the development of novel drugs by pharmaceutical companies
  • CROs held the largest revenue share of EDC systems owing to rising demand from major players in the medical device sector
  • Asia Pacific market for EDC systems is anticipated to witness highest growth rate owing to the presence of large number of outsourcing firms in this region offering cost-efficient eClinical solutions
  • The market is facing intense competition as there are many organizations that offer technologically efficient solutions for clinical data management
  • Companies are adopting strategies such as merger & acquisition, new product development, and distribution channel enhancement to gain competitive advantage

Browse related reports by Grand View Research:

  • Histology and Cytology Market - http://www.grandviewresearch.com/industry-analysis/histology-and-cytology-market

  • Live Cell Imaging Market - http://www.grandviewresearch.com/industry-analysis/live-cell-imaging-market

  • Artemisinin Market - http://www.grandviewresearch.com/industry-analysis/artemisinin-market

  • ePharmacies Market - http://www.grandviewresearch.com/industry-analysis/epharmacies-market

Grand View Research has segmented the EDC systems market on the basis of the component, delivery mode, development phase, end use, and region:

  • Global EDC Systems Component Outlook (Revenue, USD Million, 2014 - 2025)
    • Software
    • Services
  • Global EDC Systems Delivery Mode Outlook (Revenue, USD Million, 2014 - 2025)
    • Web hosted
    • Licensed enterprise
    • Cloud based
  • Global EDC Systems Development Outlook (Revenue, USD Million, 2014 - 2025)
    • Phase I
    • Phase II
    • Phase III
    • Phase IV
  • Global EDC Systems End-use Outlook (Revenue, USD Million, 2014 - 2025)
    • Hospitals
    • CROs
    • Academic institutes
    • Pharma & Biotech Organizations
    • Medical Device Manufacturers
  • EDC Systems Regional Outlook (Revenue, USD Million, 2014 - 2025)
    • North America
      • U.S.
      • Canada
    • Europe
      • UK
      • Germany
    • Asia Pacific
      • Japan
      • China
      • India
    • Latin America
      • Mexico
      • Brazil
    • MEA
      • South Africa
      • Saudi Arabia

Read Our Blog: EDC Systems Market: Increasing demand for cost-effective eClinical solutions

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. Thecompany provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: +1-415-349-0058
Toll Free: +1-888-202-9519
Email: sales@grandviewresearch.com

Web: http://www.grandviewresearch.com

© 2017 PR Newswire
Favoritenwechsel
Das Börsenjahr 2026 ist für viele Anleger ernüchternd gestartet. Tech-Werte straucheln, der Nasdaq 100 tritt auf der Stelle und ausgerechnet alte Favoriten wie Microsoft und SAP rutschen zweistellig ab. KI ist plötzlich kein Rückenwind mehr, sondern ein Belastungsfaktor, weil Investoren beginnen, die finanzielle Nachhaltigkeit zu hinterfragen.

Gleichzeitig vollzieht sich an der Wall Street ein lautloser Favoritenwechsel. Während viele auf Wachstum setzen, feiern Value-Titel mit verlässlichen Cashflows ihr Comeback: Telekommunikation, Industrie, Energie, Pharma – die „Cashmaschinen“ der Realwirtschaft verdrängen hoch bewertete Hoffnungsträger.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die genau in dieses neue Marktbild passen: solide, günstig bewertet und mit attraktiver Dividende. Werte, die nicht nur laufende Erträge liefern, sondern auch bei Marktkorrekturen Sicherheit bieten.

Jetzt den kostenlosen Report sichern – bevor der Value-Zug 2026 endgültig abfährt!

Dieses exklusive PDF ist nur für kurze Zeit gratis verfügbar.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.